首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   289篇
  免费   14篇
  国内免费   24篇
化学   54篇
力学   1篇
综合类   9篇
数学   247篇
物理学   16篇
  2024年   1篇
  2023年   4篇
  2022年   5篇
  2021年   8篇
  2020年   5篇
  2019年   9篇
  2018年   10篇
  2017年   15篇
  2016年   7篇
  2015年   5篇
  2014年   8篇
  2013年   40篇
  2012年   11篇
  2011年   8篇
  2010年   10篇
  2009年   9篇
  2008年   18篇
  2007年   14篇
  2006年   14篇
  2005年   16篇
  2004年   12篇
  2003年   13篇
  2002年   17篇
  2001年   9篇
  2000年   10篇
  1999年   11篇
  1998年   9篇
  1997年   8篇
  1996年   6篇
  1995年   3篇
  1994年   2篇
  1991年   3篇
  1990年   1篇
  1989年   2篇
  1985年   1篇
  1984年   2篇
  1982年   1篇
排序方式: 共有327条查询结果,搜索用时 15 毫秒
1.
We prove that there is a first-order sentence ϕ such that the group of all computable automorphisms of the ordering of the rational numbers is its only model among the groups that are embeddable in the group of all computable permutations. Supported by a Scheme 2 grant from the London Mathematical Society. __________ Translated from Algebra i Logika, Vol. 46, No. 5, pp. 649–662, September–October, 2007.  相似文献   
2.
3.
Automorphisms of groups acting faithfully on rooted trees are studied. We find conditions under which every automorphism of such a group is induced by a conjugation from the full automorphism group of the rooted tree. These results are applied to known examples such as Grigorchuk groups, Gupta–Sidki group, etc.  相似文献   
4.
It is shown that there is a function g on the natural numbers such that a partial Steiner triple system U on u points can be embedded in a Steiner triple system V on ν points, in such a way that all automorphisms of U can be extended to V, for every admissible ν satisfying ν > g(u). We find exponential upper and lower bounds for g. © 2005 Wiley Periodicals, Inc. J Combin Designs.  相似文献   
5.
Five non-isomorphic quasi-symmetric 2-(49, 9, 6) designs are known. They arise from extremal self-dual [50, 25, 10] codes with a certain weight enumerator. Four of them have an automorphism of order 3 fixing two points. In this paper, it is shown that there are exactly 48 inequivalent extremal self-dual [50, 25, 10] code with this weight enumerator and an automorphism of order 3 fixing two points. 44 new quasi-symmetric 2-(49, 9, 6) designs with an automorphism of order 3 are constructed from these codes.  相似文献   
6.
为了对比野生与种植青海川西獐牙菜中微量元素的变化,分别采集野生川西獐牙菜与种植青海川西獐牙菜种子采收前后的全植株,采用原子吸收光谱仪测定了其铜、锌、铁、锰、钴等微量元素含量。结果表明,野生川西獐牙菜较种植青海川西獐牙菜中微量元素含量高,种植川西獐牙菜在成熟种子采收后较采收前(花果期)铁、锰、钴、锌等元素含量高。  相似文献   
7.
Although recent decades have witnessed the synthesis of 1,3,4-thiadiazoles via phosphorus POCl3-promoted cyclization reaction, simultaneous access to 2-amino-1,3,4-thiadiazole and 2-amino-1,3,4-oxadiazole analogs remains unexpected and elusive. Herein, a detailed regiocontrolled synthesis of 2-amino-1,3,4-thiadiazoles in good to high yields with good regioselectivities from readily available thiosemicarbazides using POCl3 was disclosed. Meantime, to establish a comprehensive structure–activity relationship, 2-amino-1,3,4-oxadiazole derivatives as single regioisomers were prepared via EDCI·HCl-triggered cyclization of the thiosemicarbazide intermediates. The in vitro anti-influenza assays proved that the selected compounds with the pyrazine/pyridine ring exhibited certain inhibitory activities against influenza A virus strains A/HK/68 (H3N2) and A/PR/8/34 (H1N1) in MDCK cells. Among them, N-(adamantan-1-yl)-5-(5-(azepan-1-yl)pyrazin-2-yl)-1,3,4-thiadiazol-2-amine (4j) was the most active compound, and exhibited favorable activity with EC50 values of 3.5 μM and 7.5 μM, respectively. In addition, the molecular docking results explained the reason why compound 4j had dual inhibitory activity and revealed the reasonable binding mode of this compound with the M2-S31N and M2-WT ion channels. This compound had the potential to be further developed as an anti-influenza drug.  相似文献   
8.
We study wild embeddings of S 1 in S n which are tame in a sense introduced by Quinn. We show that if is a finitely presented group with H 1()=H 2()=0, then any finiteness obstruction K 0() can be realized on the complement of such an embedded S 1. We also realize trivially symmetric K –1() obstructions on the complements of such embeddings. For trivially symmetric , the embeddings constructed are shown to be isotopy homogeneous.  相似文献   
9.
We study automorphisms of the Hilbert scheme of n points on a generic projective K3 surface S, for any . We show that is either trivial or generated by a non‐symplectic involution and we determine numerical and divisorial conditions which allow us to distinguish between the two cases. As an application of these results we prove that, for any , there exist infinitely many admissible degrees for the polarization of the K3 surface S such that admits a non‐natural involution. This provides a generalization of the results of [7] for .  相似文献   
10.
Mushrooms, the fruiting bodies of fungi, are known for a long time in different cultures around the world to possess medicinal properties and are used to treat various human diseases. Mushrooms that are parts of traditional medicine in Asia had been extensively studied and this has led to identification of their bioactive ingredients. North America, while home to one of the world’s largest and diverse ecological systems, has not subjected its natural resources especially its diverse array of mushroom species for bioprospecting purposes: Are mushrooms native to North America a good source for drug discovery? In this review, we compile all the published studies up to September 2020 on the bioprospecting of North American mushrooms. Out of the 79 species that have been investigated for medicinal properties, 48 species (60%) have bioactivities that have not been previously reported. For a mere 16 selected species, 17 new bioactive compounds (10 small molecules, six polysaccharides and one protein) have already been isolated. The results from our literature search suggest that mushrooms native to North America are indeed a good source for drug discovery.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号